Antibiotic use and resistance in emerging economies: a situation analysis for Viet Nam.

Kinh Van Nguyen, Nga Thuy Thi Do, Arjun Chandna, Trung Vu Nguyen, Ca Van Pham, Phuong Mai Doan, An Quoc Nguyen, Chuc Kim Thi Nguyen, Mattias Larsson, Socorro Escalante, Babatunde Olowokure, Ramanan Laxminarayan, Hellen Gelband, Peter Horby, Ha Bich Thi Ngo, Mai Thanh Hoang, Jeremy Farrar, Tran Tinh Hien, Heiman F L Wertheim
Author Information
  1. Heiman F L Wertheim: Oxford University Clinical Research Unit, Hanoi, Viet Nam. heiman.wertheim@gmail.com.

Abstract

BACKGROUND: Antimicrobial resistance is a major contemporary public health threat. Strategies to contain antimicrobial resistance have been comprehensively set forth, however in developing countries where the need for effective antimicrobials is greatest implementation has proved problematic. A better understanding of patterns and determinants of antibiotic use and resistance in emerging economies may permit more appropriately targeted interventions.Viet Nam, with a large population, high burden of infectious disease and relatively unrestricted access to medication, is an excellent case study of the difficulties faced by emerging economies in controlling antimicrobial resistance.
METHODS: Our working group conducted a situation analysis of the current patterns and determinants of antibiotic use and resistance in Viet Nam. International publications and local reports published between 1-1-1990 and 31-8-2012 were reviewed. All stakeholders analyzed the findings at a policy workshop and feasible recommendations were suggested to improve antibiotic use in Viet Nam.Here we report the results of our situation analysis focusing on: the healthcare system, drug regulation and supply; antibiotic resistance and infection control; and agricultural antibiotic use.
RESULTS: Market reforms have improved healthcare access in Viet Nam and contributed to better health outcomes. However, increased accessibility has been accompanied by injudicious antibiotic use in hospitals and the community, with predictable escalation in bacterial resistance. Prescribing practices are poor and self-medication is common - often being the most affordable way to access healthcare. Many policies exist to regulate antibiotic use but enforcement is insufficient or lacking.Pneumococcal penicillin-resistance rates are the highest in Asia and carbapenem-resistant bacteria (notably NDM-1) have recently emerged. Hospital acquired infections, predominantly with multi-drug resistant Gram-negative organisms, place additional strain on limited resources. Widespread agricultural antibiotic use further propagates antimicrobial resistance.
CONCLUSIONS: Future legislation regarding antibiotic access must alter incentives for purchasers and providers and ensure effective enforcement. The Ministry of Health recently initiated a national action plan and approved a multicenter health improvement project to strengthen national capacity for antimicrobial stewardship in Viet Nam. This analysis provided important input to these initiatives. Our methodologies and findings may be of use to others across the world tackling the growing threat of antibiotic resistance.

References

  1. Trans R Soc Trop Med Hyg. 1998 Sep-Oct;92(5):503-8 [PMID: 9861362]
  2. J Med Microbiol. 2012 Mar;61(Pt 3):431-437 [PMID: 22016560]
  3. Trans R Soc Trop Med Hyg. 2011 Nov;105(11):628-36 [PMID: 21962293]
  4. Emerg Infect Dis. 2012 Aug;18(8):1383-5 [PMID: 22840532]
  5. Int J Food Microbiol. 2012 Jun 15;157(1):102-7 [PMID: 22607809]
  6. Helicobacter. 2012 Aug;17(4):319-25 [PMID: 22759333]
  7. Int J Antimicrob Agents. 2012 Apr;39(4):311-6 [PMID: 22386743]
  8. Trop Med Int Health. 2011 Jun;16(6):737-43 [PMID: 21410602]
  9. Int J Health Plann Manage. 2013 Jan-Mar;28(1):3-15 [PMID: 22715093]
  10. Int J Food Microbiol. 2012 May 15;156(2):147-51 [PMID: 22497836]
  11. Sci Total Environ. 2011 Jul 1;409(15):2894-901 [PMID: 21669325]
  12. BMC Health Serv Res. 2008 Jul 30;8:162 [PMID: 18664300]
  13. BMC Infect Dis. 2010 Mar 31;10:85 [PMID: 20356399]
  14. Antimicrob Agents Chemother. 2005 Feb;49(2):816-9 [PMID: 15673777]
  15. Am J Infect Control. 2012 Nov;40(9):840-4 [PMID: 22341530]
  16. MMWR Morb Mortal Wkly Rep. 2012 Jun 22;61(24):446-8 [PMID: 22717513]
  17. Med Ref Serv Q. 2020 Jan-Mar;39(1):67-74 [PMID: 32069199]
  18. PLoS One. 2010 Dec 13;5(12):e14170 [PMID: 21179193]
  19. Antimicrob Agents Chemother. 2007 Dec;51(12):4315-23 [PMID: 17908946]
  20. PLoS Med. 2013;10(5):e1001429 [PMID: 23667342]
  21. J Microbiol Immunol Infect. 2008 Apr;41(2):107-11 [PMID: 18473096]
  22. J Infect Chemother. 2009 Dec;15(6):384-9 [PMID: 20012729]
  23. Infect Control Hosp Epidemiol. 2007 May;28(5):583-8 [PMID: 17464919]
  24. BMC Infect Dis. 2011 Jan 06;11:6 [PMID: 21208459]
  25. J Clin Microbiol. 2007 Nov;45(11):3485-92 [PMID: 17728470]
  26. Antimicrob Agents Chemother. 2004 Jun;48(6):2101-7 [PMID: 15155207]
  27. BMC Infect Dis. 2012 Apr 18;12:92 [PMID: 22512857]
  28. PLoS Negl Trop Dis. 2011 Jun;5(6):e1163 [PMID: 21713025]
  29. Trop Med Int Health. 2000 Oct;5(10):711-21 [PMID: 11044266]
  30. Am J Infect Control. 1999 Apr;27(2):97-132; quiz 133-4; discussion 96 [PMID: 10196487]
  31. Appl Environ Microbiol. 2011 Jul;77(13):4494-8 [PMID: 21602395]
  32. Antimicrob Agents Chemother. 2000 Mar;44(3):484-8 [PMID: 10681307]

Grants

  1. 093724/Wellcome Trust

MeSH Term

Anti-Bacterial Agents
Bacterial Infections
Developing Countries
Drug Resistance, Bacterial
Drug Utilization
Health Policy
Humans
Vietnam

Chemicals

Anti-Bacterial Agents

Word Cloud

Created with Highcharts 10.0.0resistanceantibioticuseVietNamantimicrobialaccessanalysishealthemergingsituationhealthcarethreateffectivebetterpatternsdeterminantseconomiesmayfindingsagriculturalenforcementrecentlynationalBACKGROUND:AntimicrobialmajorcontemporarypublicStrategiescontaincomprehensivelysetforthhoweverdevelopingcountriesneedantimicrobialsgreatestimplementationprovedproblematicunderstandingpermitappropriatelytargetedinterventionslargepopulationhighburdeninfectiousdiseaserelativelyunrestrictedmedicationexcellentcasestudydifficultiesfacedcontrollingMETHODS:workinggroupconductedcurrentInternationalpublicationslocalreportspublished1-1-199031-8-2012reviewedstakeholdersanalyzedpolicyworkshopfeasiblerecommendationssuggestedimproveHerereportresultsfocusingon:systemdrugregulationsupplyinfectioncontrolRESULTS:MarketreformsimprovedcontributedoutcomesHoweverincreasedaccessibilityaccompaniedinjudicioushospitalscommunitypredictableescalationbacterialPrescribingpracticespoorself-medicationcommon-oftenaffordablewayManypoliciesexistregulateinsufficientlackingPneumococcalpenicillin-resistancerateshighestAsiacarbapenem-resistantbacterianotablyNDM-1emergedHospitalacquiredinfectionspredominantlymulti-drugresistantGram-negativeorganismsplaceadditionalstrainlimitedresourcesWidespreadpropagatesCONCLUSIONS:FuturelegislationregardingmustalterincentivespurchasersprovidersensureMinistryHealthinitiatedactionplanapprovedmulticenterimprovementprojectstrengthencapacitystewardshipprovidedimportantinputinitiativesmethodologiesothersacrossworldtacklinggrowingAntibioticeconomies:

Similar Articles

Cited By